Related references
Note: Only part of the references are listed.The FDA and Safe Use of Long-Acting Beta-Agonists in the Treatment of Asthma.
Badrul A. Chowdhury et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Risks of Long-Acting Beta-Agonists in Achieving Asthma Control
Jeffrey M. Drazen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Identifying and addressing safety signals in clinical trials
Thomas R. Fleming
NEW ENGLAND JOURNAL OF MEDICINE (2008)
The salmeterol multicenter asthma research trial - A comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol
HS Nelson et al.
CHEST (2006)
Share Paper
